Citations 11
Interim analysis of a prospective, randomized, double blind, placebo controlled, phase IIb trial of the TLPLDC vaccine to prevent recurrence in resected stage III or IV melanoma patients.
Myers, John W., Hale, Diane F. , Brown, Tommy A., Vreeland, Timothy J. , Andtbacka, Robert Hans Ingemar, Berger, Adam C. , Terando, Alicia M. , Faries, Mark B. , Peoples, George E. , Clifton, Guy T. , Jakub, James W. , Sussman, Jonathan
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9525-9525
